Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Voyager Therapeutics, Inc. (VYGR)  
$8.44 0.13 (1.52%) as of 4:30 Thu 5/9


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 37,470,000
Market Cap: 316.25(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $6.28 - $13.99
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Voyager Therapeutics is a gene therapy company focused on developing treatments and platform technologies. Co.'s team has developed a proprietary adeno-associated virus (AAV) capsid discovery platform called TRACER™ (Tropism Redirection of AAV by Cell Type-Specific Expression of RNA) to facilitate the selection of AAV capsids with blood brain barrier crossing and cell-specific transduction properties for particular therapeutic applications. The TRACER discovery platform is a functional RNA-based AAV capsid discovery platform that allows for rapid in vivo evolution of AAV capsids with cell-specific transduction properties in multiple species, including non-human primates.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 4,872,988
Total Buy Value $0 $0 $0 $41,694,868
Total People Bought 0 0 0 2
Total Buy Transactions 0 0 0 3
Total Shares Sold 38,202 42,011 76,578 2,756,162
Total Sell Value $317,473 $344,745 $641,708 $21,052,273
Total People Sold 4 4 4 9
Total Sell Transactions 7 9 13 45
End Date 2024-02-08 2023-11-07 2023-05-09 2022-05-09

   
Records found: 162
  Page 3 of 7  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Ecor1 Capital, Llc 10% Owner   –       –       •   2023-01-11 4 S $8.50 $934,615 I/I (110,000) 3,851,507 -55%     
   Ecor1 Capital, Llc 10% Owner   –       –       •   2023-01-10 4 S $8.05 $2,709,433 I/I (336,400) 3,961,507 -66%     
   Ecor1 Capital, Llc 10% Owner   –       –       •   2023-01-09 4 S $7.67 $3,498,295 I/I (456,000) 4,297,907 -75%     
   Carter Todd Alfred Chief Scientific Officer   •       –      –    2023-01-06 4 S $6.41 $2,487 D/D (388) 36,194 -73%     
   Carter Todd Alfred Chief Scientific Officer   •       –      –    2022-12-31 4 A $5.17 $2,006 D/D 388 36,582     -
   Pfreundschuh Peter P. Chief Financial Officer   •       –      –    2022-10-01 4 A $0.00 $0 D/D 125,000 125,000     -
   Carter Todd Alfred Chief Scientific OfficerOffice   •       –      –    2022-09-19 3 IO $0.00 $0 D/D 0 36,194 53%     
   Tepper Robert I 10% Owner   –       –       •   2022-08-25 4 S $6.22 $1,244,000 D/D (200,000) 5,428,933 -9%     
   Tepper Robert I 10% Owner   –       –       •   2022-08-24 4 S $6.09 $913,329 D/D (149,972) 5,628,933 -2%     
   Tepper Robert I 10% Owner   –       –       •   2022-08-16 4 S $6.04 $775,874 D/D (128,456) 5,778,905 9%     
   Tepper Robert I 10% Owner   –       –       •   2022-08-15 4 S $6.04 $820,280 D/D (135,808) 5,907,361 10%     
   Tepper Robert I 10% Owner   –       –       •   2022-08-12 4 S $6.12 $2,129,803 D/D (348,007) 6,043,169 8%     
   Pierce Glenn Director   –       •      –    2022-07-14 4 AS $6.70 $63,730 D/D (9,512) 16,788 -16%     
   Higgins Michael J Director   –       •      –    2022-07-14 4 AS $6.70 $93,070 D/D (13,891) 31,314 -16%     
   Ecor1 Capital, Llc 10% Owner   –       –       •   2022-06-23 4 B $5.66 $2,126,543 I/I 376,000 4,753,907 1.5 -8%     
   Ecor1 Capital, Llc 10% Owner   –       –       •   2022-06-21 4 B $5.28 $535,504 I/I 101,400 4,377,907 1.5 -2%     
   Ecor1 Capital, Llc 10% Owner   –       –       •   2022-04-21 3 IO $0.00 $0 I/I 0 4,276,507 -18%     
   Swartz Robin Chief Operating Officer   •       –      –    2022-04-04 4 AS $8.25 $12,598 D/D (1,527) 52,060 -30%     
   Hesslein Robert W. Senior VP & General Counsel   •       –      –    2022-04-04 4 AS $8.25 $22,985 D/D (2,786) 114,963 -30%     
   Sandrock Alfred President and CEO   •       •      –    2022-03-22 4 A $0.00 $0 D/D 100,000 100,000     -
   Burek Julie VP, Finance   •       –      –    2022-03-21 4 AS $8.29 $21,972 D/D (2,649) 52,458 -20%     
   Swartz Robin Chief Operating Officer   •       –      –    2022-03-21 4 AS $8.29 $36,604 D/D (4,413) 53,587 -20%     
   Hesslein Robert W. Senior VP & General Counsel   •       –      –    2022-03-21 4 AS $8.29 $41,100 D/D (4,955) 117,749 -20%     
   Burek Julie VP, Finance   •       –      –    2022-02-17 4 AS $3.55 $2,801 D/D (789) 55,107 71%     
   Hesslein Robert W. Senior VP & General Counsel   •       –      –    2022-02-17 4 AS $3.55 $14,555 D/D (4,100) 122,704 71%     

  162 Records found
  1  2  3  4  5  6  7   
  Page 3 of 7
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed